Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfenex, Glide Extend Formulation Contract | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pfenex, Glide Extend Formulation Contract

Glide to use solid dose technology for Pfenex's Px563L-mrPA

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Glide Technologies received a subcontract extension for the advancement of an alternative delivery method for Pfenex’s recombinant Protective Antigen, Px563L-mrPA, using its solid dose formulation technology. This contract continuation is the result of the National Institute of Allergy and Infectious Diseases (NIAID) exercising its first contract option under its existing contract with Pfenex.

“We are pleased with the early results and the development of this potential additional path for our anthrax vaccine program,” said Bertrand C. Liang, chief executive officer of Pfenex. “We appreciate the additional funding support provided by NIAID for this program and look forward to continuing this successful collaboration.”

“Following encouraging stability data with initial formulations we are pleased that NIAID continues to fund the progression of this program. We believe that a combination of Pfenex’s proprietary rPA-based anthrax vaccine and Glide’s novel formulations and delivery technology will address key issues with current products designed for a response to an anthrax bio-threat,” said Mark Carnegie-Brown, chief executive officer of Glide Technologies.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics